Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Is German Digital Health Care Act an under-used failure?  

In 2019, Germay passed a new law designed to revolutionize the e-health market by reimbursing therapeutic apps. Why hasn't it had more of an impact? HBI speaks with Sven Jungmann, Chief Medical Officer in Berlin-based corporate venture builderFoundersLane, to find out.

Lim and others eye up IVIRMA

Singapore billionaire Peter Lim is said to be in talks to buy IVIRMA, the Euro-American fertility player where big private equity is expected to bid high. HBI understands other bidders may include KKR, Carlyle and Cinven.

Investors choose between Affidea and IVI RMA

Big private equity players in health care face a choice as to whether to go for Pan-European imaging group Affidea which is for sale through Goldman Sachs or for IVI RMA, the international fertility group.

UK self-pay “almost doubles” to a potential 15m

The self-pay market in the UK is growing much faster than other parts of the private sector. Justin Ash, CEO of the UK’s second largest for-profit hospital group, Spire Healthcare, tells us it almost doubled to 15m people in the past two years, and will only continue to grow in the face of the NHS backlog.

FREE BLOG Here’s to Sophie!

Media firestorms exposing poor treatment in for-profit nursing homes have occurred frequently over the last decade. Normally companies respond by chucking their CEOs or by sitting tight-lipped and threatening to sue. Not Sophie Boissard at Korian.

PKV to stay

The German health care sector is breathing a sigh of relief at the news that the private PKV insurance that covers 11pc of Germans is most unlikely to be abolished by the new government. Karl Lauterbach, a fierce. critic of the parallel system who had previously described PKV as "brown coal" says its reform is a very low priority.

Find Us